Current Tuberculosis Treatment Regimens

This publication has 34 references indexed in Scilit:

• Comparative Bioavailability of Isoniazid, Rifampin, and Pyrazinamide Administered in Free Combination and in a Fixed Triple Formulation Designed for Daily Use in Antituberculosis Chemotherapy: I. Single-Dose Study
  American Review of Respiratory Disease, 1988
• Tuberculosis in Patients with the Acquired Immunodeficiency Syndrome: Clinical Features, Response to Therapy, and Survival
  American Review of Respiratory Disease, 1987
• Diagnostic Decision: Biochemical Profiles: Applications in Ambulatory Screening and Preadmission Testing of Adults
  Annals of Internal Medicine, 1987
• Standard Therapy for Tuberculosis 1985
  Chest, 1985
• Short-Course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin
  The American Journal of Medicine, 1984
• Extrapulmonary Tuberculosis Revisited
  Medicine, 1984
• Patient Compliance: The Most Serious Remaining Problem in the Control of Tuberculosis in the United States
  Chest, 1979
• Short-course Chemotherapy for Tuberculosis with Largely Twice-weekly Isoniazid-Rifampin
  Chest, 1979
• Bactericidal Activity of Streptomycin, Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Alone and In Combination Against Mycobacterium Tuberculosis¹
  American Review of Respiratory Disease, 1977
• Single Daily Dose of Antidepressants
  JAMA, 1974